Frederick Kohlhapp

Frederick Kohlhapp, Ph.D., is a highly driven clinical scientist specializing in oncology early development at AbbVie, where they currently work. With over 17 years of experience in cancer and immunology research, Kohlhapp previously held positions as a Senior Scientist in Immuno-Oncology at AbbVie and as a postdoctoral fellow at Rutgers University, University of Wisconsin-Madison, and Northwestern University. They earned a Ph.D. in Immunology from the University of Chicago and contributed to advancements in tumor immunotherapies, including developing novel immunotherapies and mentoring junior researchers.